Abstract:Highlights • The unbalanced GM homeostasis has a reciprocal causation with the development of CNS diseases. • GM and it's metabolites participate the regulation of CNS diseases via affecting the neuroinflammation level. • GM metabolites are essential for synergistic bidirectional communication between ENS and CNS. • The therapeutic strategies based on GM regulation are the good choices of the recovery of CNS diseases. Backgroud Central nervous system (CNS) diseases pose a serious threat to human health, but the regulatory mechanisms and therapeutic strategies of CNS diseases need to be further explored. It has been demonstrated that the gut microbiota (GM) is closely related to CNS disease. GM structure disorders, abnormal microbial metabolites, intestinal barrier destruction and elevated inflammation exist in patients with CNS diseases and promote the development of CNS diseases. More importantly, GM remodeling alleviates CNS pathology to some extent. Aim of review Here, we have summarized the regulatory mechanism of the GM in CNS diseases and the potential treatment strategies for CNS repair based on GM regulation, aiming to provide safer and more effective strategies for CNS repair from the perspective of GM regulation. Key scientific concepts of review The abundance and composition of GM is closely associated with the CNS diseases. On the basis of in-depth analysis of GM changes in mice with CNS disease, as well as the changes in its metabolites, therapeutic strategies, such as probiotics, prebiotics, and FMT, may be used to regulate GM balance and affect its microbial metabolites, thereby promoting the recovery of CNS diseases. Graphical abstract Download : Download high-res image (163KB) Download : Download full-size image

Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance